Important Safety And Efficacy Information On Albrioza (sodium Phenylbutyrate And Ursodoxicoltaurine) – Market Withdrawal And Continued Restricted Access
ALBRIOZA, a medication containing sodium phenylbutyrate and ursodoxicoltaurine, is being withdrawn from the Canadian market due to new safety information. The drug was distributed across Canada. Healthcare providers and patients who use or prescribe this medication are affected by this withdrawal.
- Product
- LBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine)
- Reason
- New safety information - Product withdrawal
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-06-07
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/b062bfec-7fe0-437b-bf85-d99a0751db45